Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 826 participants.
Also called NCT04135677
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 826 participants
- Sponsor
- Registry
-
NCT04135677
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04135677. Randomized; triple masking; primary purpose prevention. Start 2022-11-11 (actual); primary completion 2024-10-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO
- Condition
- Left Atrial Appendage Thrombosis
- Condition
- Thrombi
- Condition
- Stroke
- Intervention (Drug)
- Rivaroxaban
- Intervention (Drug)
- DAPT
- Lead sponsor
- Shanghai Zhongshan Hospital
Record details
- Record id
cardio:ct-nct04135677- Content hash
8595bf02c856529d3e3ee147ebf063adaacd61048630753f182a3cc589ffe2b4